Unique ID issued by UMIN | UMIN000003416 |
---|---|
Receipt number | R000004138 |
Scientific Title | Cohort study of bevacizumab in combination with XELOX for metastatic colorectal cancer |
Date of disclosure of the study information | 2010/04/01 |
Last modified on | 2014/04/08 20:01:16 |
Cohort study of bevacizumab in combination with XELOX for metastatic colorectal cancer
Cohort study of bevacizumab in combination with XELOX for metastatic colorectal cancer
Cohort study of bevacizumab in combination with XELOX for metastatic colorectal cancer
Cohort study of bevacizumab in combination with XELOX for metastatic colorectal cancer
Japan |
Colorectal Cancer
Gastroenterology | Gastrointestinal surgery |
Malignancy
NO
To assess the drug administration situation (drug compliance situation, post-treatment, etc ) in colorectal cancer patients who receive XELOX+BV as initial therapy
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
ORR; overall response rate
drug administration situation (drug compliance situation, post-treatment, etc )
liver resection rate
R0 liver resection rate
TTF:time to treatment-failure
PFS:progression-free survival
OS :Overall survival
adverse effects
Observational
Not applicable |
Not applicable |
Male and Female
1.colorectal cancer cytologically and or histrogically
2.bidimensionally measurable disease no prior treatment for metastatic disease
3.XELOX+BV can be treatable
4.written informed consents
1.Synchronous or metachronous multiple cancers
2. Contraindication of bevacizumab oxaliplatin and capecitabine
3.Investigators considers not suitable for the study
40
1st name | |
Middle name | |
Last name | Husao Ikeda |
West Kobe Medical Center
Department of surgery
5-7-1 Kohjidai Nishi-ku Kobe-City, 651-2273,JAPAN
078-997-2200
fikeda@kuhp.kyoto-u.ac.jp
1st name | |
Middle name | |
Last name | Masahito Kotaka Rieko Yoneda |
Sano Hospital
Digestive Disease Center
2-5-1 Simizugaoka Tarumi-ku Kobe-City,655-0031,JAPAN
078-785-1000
tomomakotaka6410@yahoo.co.jp
Sano Hospital
none
Self funding
NO
2010 | Year | 04 | Month | 01 | Day |
Partially published
No longer recruiting
2010 | Year | 03 | Month | 03 | Day |
2010 | Year | 04 | Month | 01 | Day |
2014 | Year | 06 | Month | 30 | Day |
2014 | Year | 12 | Month | 31 | Day |
2014 | Year | 12 | Month | 31 | Day |
2014 | Year | 12 | Month | 31 | Day |
ORR; overall response rate
drug administration situation (drug compliance situation, post-treatment, etc )
liver resection rate
R0 liver resection rate
TTF:time to treatment-failure
PFS:progression-free survival
OS :Overall survival
adverse effects
2010 | Year | 03 | Month | 31 | Day |
2014 | Year | 04 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004138
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |